7232Cx Maximo VR
Implantable Cardioverter Defibrillator (ICD)
7232Cx Maximo VR
Information

Device Survival Probability

7232_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr 9 yr 10 yr 11 yr 12 yr 13 yr 14 yr              
% Excluding Normal Battery Depletion 100.0 99.9 99.9 99.8 99.8 99.8 99.8 99.8 99.8 99.8 99.8 99.8 99.8 99.8              
% Including Normal Battery Depletion 99.3 99.0 98.6 98.1 96.5 90.5 81.9 69.4 42.8 14.6 8.9 7.6 6.5 5.2              
#   37883 33854 30119 26477 23219 20035 16769 13189 7447 2009 902 608 394 121              
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Customer Communications For This Model

  • There are no communications for this model.
Information

Product Characteristics

Generator Type ICD
NBD Code VVE-VVIR
Max. Delivered Energy 35J
More
Connector Style Cx Style
Serial Number Prefix PRN
Mass 76g
Volume 39cc
Waveform Biphasic
X-Ray ID PRN
Hide this content
Cx Style
Information

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly 4.4 4.7 4.8 4.9
Quarterly 7.0 7.5 8.0 8.3
Semi-annual 8.2 9.0 9.7 10.0
Footnote

Longevity estimates based on the following device usage. Pacing Mode VVI; Ventricular Lower Pacing Rate 60ppm; Ventricular Pulse Width 0.4ms; Ventricular Pulse Amplitude 3V; Ventricle Impedance 510ohms; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content

Information

Distribution Data

US Market Release2003-10-06
CE Approval Date2003-10-28
Registered USA Implants43532
Estimated Active USA Implants2807
Normal Battery Depletions10325
US Market Release2003-10-06
CE Approval Date2003-10-28
Estimated WW Distribution75205
Normal Battery Depletions10661
Information

Malfunctions (USA)

Therapy Function Not Compromised 57
Electrical Component 28
Possible Early Battery Depletion 25
Software/Firmware 2
Other 2
Therapy Function Compromised 15
Electrical Component 12
Electrical Interconnect 1
Possible Early Battery Depletion 1
Other 1
Information

Malfunctions (WW)

Therapy Function Not Compromised 115
Battery 2
Electrical Component 70
Possible Early Battery Depletion 35
Software/Firmware 5
Other 3
Therapy Function Compromised 23
Electrical Component 20
Electrical Interconnect 1
Possible Early Battery Depletion 1
Other 1
Information

EOL Indication

EOL device status is defined as three months following an ERI indication assuming the following post-ERI conditions: 100% VVI pacing at 60 ppm, 3 V, 0.4 ms; 500 Ohm pacing load; and six 30 J charges. EOL may be indicated before the end of three months if the device exceeds these conditions.

Information

Elective Replacement (ERI)

Battery voltage less than or equal to 2.62v or charge time greater than 16 seconds.

Information

Charge Time

7232_CHRG
Loading...

Data as of December 16, 2021

www.medtronic.com/productperformance 851050